×
Türk, U. Ö., Alioğlu, E., Mavioğlu, Z., Diker, E., Özpelit, E., & De Caterina, R. (2022). Evaluation of Treatment Safety in Patients with Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey Study: Design and Rationale. Turk Kardiyol Dern Ars, 50(2), 117-123. https://doi.org/10.5543/tkda.2022.21065.
Türk UÖ, Alioğlu E, Mavioğlu Z, Diker E, Özpelit E, De Caterina R. Evaluation of Treatment Safety in Patients with Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey Study: Design and Rationale. Turk Kardiyol Dern Ars. 2022 March;50(2):117-123. doi:10.5543/tkda.2022.21065.
Türk UÖ, Alioğlu E, Mavioğlu Z, et al. Evaluation of Treatment Safety in Patients with Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey Study: Design and Rationale. Turk Kardiyol Dern Ars. 2022;50(2):117-123. doi:10.5543/tkda.2022.21065.
Türk, Uğur Önsel et al. "Evaluation of Treatment Safety in Patients with Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey Study: Design and Rationale." Turk Kardiyol Dern Ars vol. 50,2 (2022): 117-123. doi:10.5543/tkda.2022.21065.
Türk, Uğur Önsel, Emin Alioğlu, Zafer Mavioğlu, Erdem Diker, Ebru Özpelit and Raffaele De Caterina "Evaluation of Treatment Safety in Patients with Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey Study: Design and Rationale." Turk Kardiyol Dern Ars 50, no. 2 (2022): 117-123. https://doi.org/10.5543/tkda.2022.21065.
Copied!